HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Syphilis].

Abstract
Syphilis is back since 2000. Early syphilis comprises primary syphilis, secondary syphilis and early latent syphilis (less than 1 year duration). During early phases of syphilis, patients are more contagious and neurologic complications are rare. Early neurosyphilis are mostly represented by uveitis or cranial nerves lesions. Treatment of non-neurologic syphilis are based on intramusculary injection of benzathine-penicilline G: one injection in case of early syphilis, three injections in case of late syphilis. The follow-up after treatment is based on clinical evolution and the titer of VDRL. Intravenously infusion of penicillin G is the only treatment recommended for neurosyphilis.
AuthorsNicolas Dupin, David Farhi
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 42 Issue 4 Pt 1 Pg. 446-53 (Apr 2013) ISSN: 2213-0276 [Electronic] France
Vernacular TitleSyphilis.
PMID23414811 (Publication Type: English Abstract, Journal Article, Review)
CopyrightCopyright © 2013 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Penicillin G
  • Penicillin G Benzathine
Topics
  • Adult
  • Cross-Cultural Comparison
  • Cross-Sectional Studies
  • Drug Administration Schedule
  • Early Diagnosis
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Infusions, Intravenous
  • Injections, Intramuscular
  • Male
  • Neurosyphilis (diagnosis, drug therapy, epidemiology, transmission)
  • Penicillin G (therapeutic use)
  • Penicillin G Benzathine (therapeutic use)
  • Population Surveillance
  • Pregnancy
  • Syphilis (diagnosis, drug therapy, epidemiology, transmission)
  • Syphilis, Cutaneous (diagnosis, drug therapy, epidemiology, transmission)
  • Syphilis, Latent (diagnosis, drug therapy, epidemiology, transmission)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: